BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

INDRAYANIBIOTECH01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

INDRAYANIBIOTECH01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
26-Apr-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Indrayani Biotech Ltd. (Scrip Code - 526445) are listed and permitted to trade on the Exchange with effe	29-Apr-2024
19-Feb-2024	BC	Source: BSE Announcement PDF	17-Feb-2024
10-Jan-2024	BC	The Board of Directors of the Company, at their meeting held on today, January 10, 2024, have inter-alia considered and approved the following matters: Recommendations to get approval from shareholde	14-Feb-2024
04-Feb-2024	BC	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve INDRAYANI BIOTECH LIMITED has informed B	10-Feb-2024
10-Jan-2024	BC	Took note of the resignation of Mr. Rajesh Kumar Sundarray (ACS membership number: A66744) as Company Secretary & Compliance Officer with effect from closing hours on January 10, 2024 and has appoint	11-Jan-2024

No Rights has been declared by INDRAYANIBIOTECH

Book Closure

Record Date	Split Date	Purpose
29-Apr-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Indrayani Biotech Ltd. (Scrip Code - 526445) are listed and permitted to trade on the Exchange with effe
17-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF
14-Feb-2024	01 Jan'1900	The Board of Directors of the Company, at their meeting held on today, January 10, 2024, have inter-alia considered and approved the following matters: Recommendations to get approval from shareholde
10-Feb-2024	-	INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve INDRAYANI BIOTECH LIMITED has informed B
11-Jan-2024	-	Took note of the resignation of Mr. Rajesh Kumar Sundarray (ACS membership number: A66744) as Company Secretary & Compliance Officer with effect from closing hours on January 10, 2024 and has appoint

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
HLV Ltd ₹27.60(-0.30/-1.08%)	27.60	-0.30	1,839.34	155.96	86.84	4.34
The Byke Hospitality Ltd ₹78.40(-0.40/-0.51%)	78.40	-0.40	315.97	90.80	57.09	1.95
Indian Hotels Co Ltd ₹573.30(+2.70/0.47%)	573.30	+2.70	81,221.04	60.78	70.83	8.01
TGB Banquets & Hotels Ltd ₹15.05(+0.10/0.67%)	15.05	+0.10	43.79	60.75	28.75	0.56
Speciality Restaurants Ltd ₹188.05(-3.55/-1.85%)	188.05	-3.55	921.55	-16.73	12.88	3.08

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	13.69	16.01	16.82	21.30	21.66	15.92
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	13.69	16.01	16.82	21.30	21.66	15.92
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.08	0.09	0.01	0.15	0.04	0.06
Total Income	13.77	16.10	16.82	21.46	21.70	15.98
Total Expenditure	12.36	14.71	14.79	18.86	19.27	13.96
PBIDT	1.41	1.39	2.04	2.60	2.43	2.02
Interest	0.78	0.62	0.96	1.24	0.58	0.57
PBDT	0.63	0.77	1.08	1.36	1.84	1.45
Depreciation	0.37	0.37	0.36	0.48	0.17	0.16
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.26	0.41	0.72	0.87	1.67	1.30
Extra-ordinary Items	0.00	0.00	0.00	0.00	-0.25	0.00
Adjusted Profit After Extra-ordinary item	0.26	0.41	0.72	0.87	1.92	1.30

EPS (Unit Curr.)	0.06	0.12	0.21	0.25	0.49	0.38
EPS (Adj) (Unit Curr.)	0.06	0.12	0.21	0.25	0.49	0.38
Calculated EPS (Unit Curr.)	0.06	0.12	0.21	0.25	0.49	0.38
Calculated EPS (Adj) (Unit Curr.)	0.06	0.12	0.21	0.25	0.49	0.38
Calculated EPS (Ann.) (Unit Curr.)	0.23	0.47	0.84	1.02	1.95	1.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.23	0.47	0.84	1.02	1.95	1.51
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	45.54	34.23	34.23	34.23	34.23	34.23
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.30	8.68	12.13	12.21	11.22	12.69
PBDTM(%)	4.60	4.81	6.42	6.38	8.49	9.11
PATM(%)	1.90	2.56	4.28	4.08	7.71	8.17

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	39.09	40.44	42.31	49.25	46.00	42.05
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	39.09	40.44	42.31	49.25	46.00	42.05
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.08	0.09	0.01	2.05	0.08	1.96
Total Income	39.18	40.53	42.32	51.30	46.07	44.02
Total Expenditure	35.65	33.15	39.78	46.07	40.67	36.86
PBIDT	3.52	7.39	2.54	5.22	5.41	7.16
Interest	1.41	0.93	2.03	2.23	1.21	1.15
PBDT	2.12	6.45	0.52	3.00	4.20	6.01
Depreciation	1.03	0.91	0.90	1.15	0.78	0.75
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.06	0.20	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.20	-0.03	0.00
Reported Profit After Tax	1.08	5.54	-0.45	1.44	3.44	5.26
Minority Interest After NP	0.00	0.00	0.00	0.36	0.98	0.00
Net Profit after Minority Interest	1.08	5.54	-0.45	1.08	2.46	5.26

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.08	5.54	-0.45	1.08	2.46	5.26

EPS (Unit Curr.)	0.22	0.91	-0.06	0.32	0.72	1.47
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	45.54	34.23	34.23	34.23	34.23	34.23

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	9.00	18.27	6.00	10.60	11.76	17.03
PBDTM(%)	5.42	15.95	1.23	6.09	9.13	14.29
PATM(%)	2.76	13.70	-1.06	2.92	7.48	12.51

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	43.48	34.23	34.23	3.64	3.64	3.64
Reserves Total	6.13	-10.05	-14.28	-3.39	-4.30	-4.25
Equity Share Warrants	1.54	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	30.58	0.00	0.00
Total Shareholders Funds	51.15	24.18	19.95	30.83	-0.66	-0.61
Secured Loans	35.27	16.73	15.43	13.05	0.00	0.00
Unsecured Loans	8.97	0.00	0.00	0.69	0.64	0.60
Total Debt	44.24	16.73	15.43	13.74	0.64	0.60
Total Liabilities	95.39	40.91	35.38	44.57	-0.02	-0.01
APPLICATION OF FUNDS :
Gross Block	26.50	17.09	16.53	18.38	0.00	0.00
Less : Accumulated Depreciation	2.69	1.76	1.42	1.01	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	23.81	15.33	15.11	17.37	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	12.72	13.22	13.72	13.59	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	7.99	0.19	0.19	0.01	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.86	1.37	1.08	5.07	0.00	0.00
Sundry Debtors	16.23	12.88	4.77	7.04	0.00	0.00
Cash and Bank	0.62	1.45	0.63	1.40	0.01	0.01
Loans and Advances	30.62	2.31	2.56	5.68	0.00	0.00
Total Current Assets	49.33	17.99	9.04	19.20	0.01	0.01
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	3.03	7.20	3.61	6.75	0.01	0.00
Provisions	1.86	1.32	0.85	0.14	0.01	0.01
Total Current Liabilities	4.90	8.52	4.46	6.89	0.02	0.01
Net Current Assets	44.44	9.48	4.58	12.31	-0.01	0.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.01	0.01	0.01	0.01	0.00	0.00
Net Deferred Tax	-0.01	-0.01	-0.01	-0.01	0.00	0.00
Total Assets	88.94	38.21	33.59	43.27	-0.01	0.00
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 12	Mar 11
SOURCES OF FUNDS :
Share Capital	43.48	34.23	34.23	3.64	3.69	3.70
Reserves Total	10.07	-10.06	-14.51	-3.39	-0.18	-0.12
Equity Share Warrants	1.54	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	30.58	0.00	0.00
Total Shareholders Funds	55.09	24.17	19.72	30.83	3.51	3.58
Minority Interest	-6.73	0.41	0.36	0.00	0.00	0.00
Secured Loans	62.75	17.89	15.54	13.05	0.00	0.00
Unsecured Loans	7.44	0.91	0.00	0.69	0.00	0.00
Total Debt	70.19	18.80	15.54	13.74	0.00	0.00
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	118.55	43.38	35.62	44.57	3.51	3.58
APPLICATION OF FUNDS :
Gross Block	88.86	58.19	16.85	18.38	6.15	6.09
Less: Accumulated Depreciation	31.38	41.68	1.47	1.01	0.56	0.28
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	57.48	16.51	15.38	17.37	5.59	5.81
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	13.74	13.27	13.72	13.59	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.22	0.00	0.01	0.01	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.21	1.53	1.09	5.07	0.00	0.00
Sundry Debtors	29.97	14.10	4.77	7.04	4.20	2.84
Cash and Bank	3.04	1.50	0.68	1.40	1.19	0.24
Loans and Advances	32.30	1.78	2.62	5.68	1.31	0.72
Total Current Assets	77.52	18.91	9.15	19.20	6.70	3.80
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	33.49	6.55	3.52	6.75	8.52	5.85
Provisions	3.92	1.48	0.91	0.14	0.07	0.06
Total Current Liabilities	37.41	8.03	4.43	6.89	8.59	5.91
Net Current Assets	40.11	10.89	4.72	12.31	-1.89	-2.11
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.04	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.01	0.01	0.01	0.01	0.19	0.12
Net Deferred Tax	0.03	-0.01	-0.01	-0.01	-0.19	-0.12
Other Assets	6.96	2.71	1.80	1.31	0.00	0.00
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.45	0.63	1.40	0.39	0.01
Net Cash from Operating Activities	8.33	3.47	0.52	5.96	-0.21
Net Cash Used In Investing Activities	-14.09	0.59	-0.56	-3.67	0.00
Net Cash Used In Financing Activities	4.93	-3.23	-0.73	-1.28	0.20
Net Inc./Dec In Cash And Cash Equivalents	-0.83	0.82	-0.78	1.01	0.00
Cash And Cash Equivalents At End Of The Year	0.62	1.45	0.63	1.40	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

33.57%

FII Shareholding

0.00%

DII Shareholding

6.75%

Public Shareholding

59.68%

**Promoter pledged shareholding 33.57%

About Indrayani Biotech Ltd

Indrayani Biotech Ltd is in the Hotels & Restaurants sector, having a market capitalization of Rs. 194.49 crores. It has reported a sales of Rs. 13.69 crores and a net profit of Rs. 0.26 crores for the quarter ended December 2018. The company management includes N M Ranganathan, Kasiraman Sayee Sundar,Singarababu Indirakumar,Muthu Krishnan Ramesh,K S Vaidyanathan,G Swaminathan,Lakshmi Prabha,N M Ranganathan,B N Padmaja Priyadarshini,V Santhana Krishnan (Indrayani Biotech Ltd) among others.

Chairman

N M Ranganathan

Registered office

1133/5 F C Road,Opp Police Grounds,Pune,Maharashtra,411016

FAX :

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0